Pharmsville팜스빌
318010 · KOSDAQ · ₩318010 · 팜스빌
₩3,390▲ ₩45 (1.35%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩2.4B | ₩2.5B | ₩3B | ₩3.4B | ₩3.1B | ₩3.3B | ₩3.6B | ₩4.2B |
| Cost of sales | ₩814M | ₩857M | ₩1.2B | ₩1.2B | ₩1.1B | ₩1.2B | ₩1.3B | ₩1.6B |
| Gross profit | ₩1.6B | ₩1.6B | ₩1.7B | ₩2.2B | ₩1.9B | ₩2.2B | ₩2.3B | ₩2.6B |
| Operating income | −₩162M | −₩55M | −₩351M | −₩119M | −₩292M | ₩89M | −₩184M | −₩213M |
| Net income | ₩475M | ₩1.2B | ₩831M | ₩500M | ₩466M | ₩1.1B | ₩950M | ₩245M |
| Net income to shareholders | ₩466M | ₩1.2B | ₩824M | ₩494M | ₩466M | ₩1.1B | ₩949M | ₩245M |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩68B | ₩69B | ₩69B | ₩69B | ₩68B | ₩68B | ₩67B | ₩69B |
| Current assets | ₩38B | ₩42B | ₩41B | ₩42B | ₩40B | ₩41B | ₩41B | ₩43B |
| Cash and equivalents | ₩4.9B | ₩6.5B | ₩1.7B | ₩2.6B | ₩2.3B | ₩2.8B | ₩18B | ₩5.3B |
| Total liabilities | ₩1.7B | ₩1.6B | ₩2B | ₩2.6B | ₩2.3B | ₩2.9B | ₩2.5B | ₩5.8B |
| Current liabilities | ₩1.6B | ₩1.5B | ₩1.9B | ₩2.2B | ₩2B | ₩2.5B | ₩2.2B | ₩3.8B |
| Borrowings | ₩9.4M | — | — | ₩0 | — | — | — | ₩545M |
| Total equity | ₩67B | ₩68B | ₩67B | ₩66B | ₩65B | ₩65B | ₩65B | ₩64B |
| Shareholders' equity | ₩67B | ₩68B | ₩66B | ₩66B | ₩65B | ₩65B | ₩65B | ₩64B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩1.1B | −₩7.3M | ₩210M | ₩272M | ₩1B | ₩367M | −₩1.6B | −₩176M |
| Capital spending | — | — | ₩0 | ₩0 | — | — | ₩5M | ₩6.5M |
| Free cash flow | ₩1.1B | −₩7.3M | ₩210M | ₩272M | ₩1B | ₩367M | −₩1.6B | −₩182M |
| Dividends paid | — | — | ₩1.5B | −₩1.5B | ₩0 | ₩773M | ₩0 | ₩0 |
Consolidated where available. Amounts in won.
Also known as: Pharmsville / 팜스빌 / 318010 / KRX:318010
Source: KRX statistical information